The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways

The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathwaysThe oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways, Published online: 04 September 2018; doi:10.1038/s41401-018-0034-6The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways

Source: Acta Pharmacologica Sinica - September 4, 2018 Category: Drugs & Pharmacology Authors: Hang Li Zhen Wang Mian Jiang Run-ping Fang Hui Shi Yu Shen Xiao-li Cai Qian Liu Kai Ye Sai-jun Fan Wei-ying Zhang Li-hong Ye Source Type: research